Candel Therapeutics (CADL) Interest Coverage Ratio (2022 - 2023)
Historic Interest Coverage Ratio for Candel Therapeutics (CADL) over the last 2 years, with Q4 2023 value amounting to 2.28.
- Candel Therapeutics' Interest Coverage Ratio rose 11629.8% to 2.28 in Q4 2023 from the same period last year, while for Dec 2023 it was 14.79, marking a year-over-year increase of 16527.68%. This contributed to the annual value of 15.97 for FY2024, which is 792.72% up from last year.
- According to the latest figures from Q4 2023, Candel Therapeutics' Interest Coverage Ratio is 2.28, which was up 11629.8% from 13.25 recorded in Q3 2023.
- Over the past 5 years, Candel Therapeutics' Interest Coverage Ratio peaked at 2.28 during Q4 2023, and registered a low of 20.12 during Q2 2022.